Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of British Columbia

$41,000.00

Epigenetics and chromatin remodeling: deciphering the molecular architecture of silent chromatin domains

EF 2010-11

Résumé
The genes of all higher organisms are packaged with special proteins into a complex structure called chromatin. While every cell contains the same set of genes, each tissue type expresses a specific suite of genes, which gives that tissue its unique identity. Thus, some genes must be expressed while others are silenced. The first level of gene regulation occurs via alterations in the chromatin architecture surrounding a gene, the chromatin domain. A chromatin domain exists either in an 'open' or a 'closed' state, thus enabling or silencing gene expression, respectively. This phenomenon is called epigenetic regulation and it has been the subject of intense study for the past decade. Understanding epigenetic regulation is essential for understanding normal developmental processes and it is absolutely critical to understanding disease states, such as cancer. Our lab was one of the first to develop a method for identifying chromatin proteins. Many labs, worldwide, now work on how these proteins function and the mechanism by which chromatin is remodeled to create a 'closed' vs. 'open' domain. The chromatin proteins are very highly conserved and their function in humans is nearly identical to that in model organisms. Each lab has been working on its favorite protein in its favorite organism. While this is the normal course of scientific study, it has led to some contradictions about the precise role of these chromatin proteins. We are now in a position to unify these findings by studying all the known silencing proteins at a single locus, the histone gene complex (HIS-C) in Drosophila. Our previous studies have shown that all proteins are present at HIS-C and have allowed us to collect all of the tools (mutations, genetic strains, antibodies, etc.) and various assay technologies needed to conduct a these analyses. We will define the order of action of the proteins, their precise function in remodeling the chromatin architecture, and show how mutations in the genes that encode these chromatin proteins alter gene expression. Our findings are fundamental to understanding of the control of normal development processes, and have important consequences for the treatment of a variety of diseases, including cancer.
Programme
Discovery Grants Program - Individual
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
3005-2009
Name nom
Grigliatti, ThomasAnthony
Department département
Zoology
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2009
Award amount
41000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
33
Committee name en
Molec. & Develop. Genetics
Committee name fr
Gén. moléculaire et dévelop.
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5303
Research subject group en
Molecular biology
Research subject group fr
Biologie moléculaire
Research subject en
Gene regulation
Research subject fr
Régulation des gènes
Partie
2
Nb partie
5
Application title
Epigenetics and chromatin remodeling: deciphering the molecular architecture of silent chromatin domains
Keyword
NSERC
Application summary
The genes of all higher organisms are packaged with special proteins into a complex structure called chromatin. While every cell contains the same set of genes, each tissue type expresses a specific suite of genes, which gives that tissue its unique identity. Thus, some genes must be expressed while others are silenced. The first level of gene regulation occurs via alterations in the chromatin architecture surrounding a gene, the chromatin domain. A chromatin domain exists either in an 'open' or a 'closed' state, thus enabling or silencing gene expression, respectively. This phenomenon is called epigenetic regulation and it has been the subject of intense study for the past decade. Understanding epigenetic regulation is essential for understanding normal developmental processes and it is absolutely critical to understanding disease states, such as cancer. Our lab was one of the first to develop a method for identifying chromatin proteins. Many labs, worldwide, now work on how these proteins function and the mechanism by which chromatin is remodeled to create a 'closed' vs. 'open' domain. The chromatin proteins are very highly conserved and their function in humans is nearly identical to that in model organisms. Each lab has been working on its favorite protein in its favorite organism. While this is the normal course of scientific study, it has led to some contradictions about the precise role of these chromatin proteins. We are now in a position to unify these findings by studying all the known silencing proteins at a single locus, the histone gene complex (HIS-C) in Drosophila. Our previous studies have shown that all proteins are present at HIS-C and have allowed us to collect all of the tools (mutations, genetic strains, antibodies, etc.) and various assay technologies needed to conduct a these analyses. We will define the order of action of the proteins, their precise function in remodeling the chromatin architecture, and show how mutations in the genes that encode these chromatin proteins alter gene expression. Our findings are fundamental to understanding of the control of normal development processes, and have important consequences for the treatment of a variety of diseases, including cancer.